Search This Blog:    HIV   MPOX

DeutschEspañolFrançaisItaliano

 


ViiV submits regulatory application to EMA for investigational HIV combo

Cabotegravir is an investigational integrase inhibitor currently in development by ViiV Healthcare for the treatment and prevention of HIV, and is not ...


View article...

Top stories of the last 30 days